wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41385777-2FB6F014-D2A6-419F-BFEE-7EBBB8D1C08D
Q41385777-2FB6F014-D2A6-419F-BFEE-7EBBB8D1C08D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41385777-2FB6F014-D2A6-419F-BFEE-7EBBB8D1C08D
A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma.
P2860
Q41385777-2FB6F014-D2A6-419F-BFEE-7EBBB8D1C08D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41385777-2FB6F014-D2A6-419F-BFEE-7EBBB8D1C08D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
654e72900e189367822a1c6aaa6c0d48c8626cb0
P2860
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.